A Review on the Paper Entitled: "The Cost-Utility Analysis of PET-Scan in the Diagnosis and Treatment of Non-Small Cell Lung Carcinoma in Iran

被引：1
|
作者：
Alipour, Vahid [1 ]
Bakhsh, Ahmad Fayaz [1 ]
机构：
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran
来源：
IRANIAN JOURNAL OF RADIOLOGY | 2014年 / 11卷 / 04期
关键词：
Analysis; PET Scan; Carcinoma; Iran;
D O I：
10.5812/iranjradiol.18738
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Cost-Utility Analysis of PET-Scan in Diagnosis and Treatment of Non-Small Cell Lung Carcinoma in Iran
    Sari, Ali Akbari
    Ravaghi, Hamid
    Mobinizadeh, Mohammadreza
    Sarvari, Sima
    IRANIAN JOURNAL OF RADIOLOGY, 2013, 10 (02) : 61 - 67
  • [2] Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung Cancer
    Lairson, David R.
    Parikh, Rohan C.
    Cormier, Janice N.
    Chan, Wenyaw
    Du, Xianglin L.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (06) : 271 - +
  • [3] COST-UTILITY OF BEVACIZUMAB WITH PC REGIMEN IN NON-SMALL CELL LUNG CANCER TREATMENT
    Nguyen, T. T. T.
    Tran, T. T. H.
    VALUE IN HEALTH, 2014, 17 (07) : A725 - A725
  • [4] Cost-utility analysis of hypofractionated Radiotherapy in non-small cell Lung cancer (NSCLC) in early Stages
    Savyon, M.
    Blanck, O.
    Andratschke, N.
    Hildebrandt, G.
    Rentzsch, O.
    Dunst, J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 37 - 37
  • [5] The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer
    Schrevens, L
    Lorent, N
    Dooms, C
    Vansteenkiste, J
    ONCOLOGIST, 2004, 9 (06): : 633 - 643
  • [6] PET scan in the staging of non-small cell lung cancer
    Vansteenkiste, JF
    LUNG CANCER, 2003, 42 : S27 - S37
  • [7] COST-UTILITY ANALYSIS OF LORLATINIB FOR FIRST-LINE TREATMENT FOR ALK POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER IN CHINA
    He, X.
    Fu, S.
    VALUE IN HEALTH, 2023, 26 (12) : S63 - S63
  • [8] COST-UTILITY ANALYSIS OF GEFITINIB AND EGFR MUTATION TESTING AS THE FIRST-LINE TREATMENT FOR NON-SMALL CELL LUNG CANCER IN VIETNAM
    Tran, T. T.
    VALUE IN HEALTH, 2017, 20 (05) : A112 - A112
  • [9] Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand
    Permsuwan, Unchalee
    Thongprasert, Sumitra
    Sirichanchuen, Buntitabhon
    VALUE IN HEALTH REGIONAL ISSUES, 2020, 21 : 9 - 16
  • [10] Cost-Utility Analysis of SBRT vs. Surgery for Patients with Stage I Non-Small Cell Lung Cancer in Japan
    Onishi, H.
    Igarashi, A.
    Shioyama, Y.
    Takayama, K.
    Matsuo, Y.
    Matsumo, Y.
    Yamashita, H.
    Miyakawa, A.
    Matsushita, H.
    Aoki, M.
    Nihei, K.
    Kimura, T.
    Koba, R.
    Lee, D.
    Ito, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E53 - E54
12345